TEZOSENTAN
- Product Name
- TEZOSENTAN
- CAS No.
- 180384-57-0
- Chemical Name
- TEZOSENTAN
- Synonyms
- RO 610612;TEZOSENTAN;N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl;N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5;N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5-isopropylpyridine-2-sulfonamide;N-[6-(2-Hydroxyethoxy)-5-(2-Methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyriMidinyl]-5-(1-Methylethyl)-2-pyridinesulfonaMide;2-Pyridinesulfonamide, N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyrimidinyl]-5-(1-methylethyl)-
- CBNumber
- CB6790143
- Molecular Formula
- C27H27N9O6S
- Formula Weight
- 605.62
- MOL File
- 180384-57-0.mol
TEZOSENTAN Property
- Melting point:
- 198-200°
- Boiling point:
- 761.2±70.0 °C(Predicted)
- Density
- 1.432±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- Soluble in DMSO
- pka
- 2.93±0.10(Predicted)
- form
- Solid
- color
- Off-white to gray
N-Bromosuccinimide Price
- Product number
- T321500
- Product name
- Tezosentan
- Packaging
- 100mg
- Price
- $14025
- Updated
- 2021/12/16
- Product number
- 099433
- Product name
- N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5-isopropylpyridine-2-sulfonamide
- Purity
- 95+%
- Packaging
- 1g
- Price
- $4725
- Updated
- 2021/12/16
- Product number
- API0008885
- Product name
- TEZOSENTAN
- Purity
- 95.00%
- Packaging
- 25MG
- Price
- $8373.75
- Updated
- 2021/12/16
- Product number
- API0008885
- Product name
- TEZOSENTAN
- Purity
- 95.00%
- Packaging
- 50MG
- Price
- $10106.25
- Updated
- 2021/12/16
- Product number
- 62074
- Product name
- Tezosentan
- Packaging
- 100mg
- Price
- $13750
- Updated
- 2021/12/16
TEZOSENTAN Chemical Properties,Usage,Production
Uses
A potent dual endothelian (ETA/ETB) receptor antagonist optimized from Bosentan (B675900). It is used in the treatment of congestive heart failure.
Uses
A potent dual endothelian (ETA/ETB) receptor antagonist optimized from Bosentan (B675900). Tezosentan is used in the treatment of congestive heart failure.
in vivo
In pithed Wistar rats, Tezosentan dose-dependently inhibits the pressor effect of big ET-1 (P<0.001 at all doses). At the lowest dose tested of 1 mg/kg, Tezosentan inhibits the pressor effect of the various doses of big ET-1 by 50 to 80%. Tezosentan has no effect by itself on blood pressure in these pithed rats. Tezosentan is very effective in a rat model of acute renal failure. ET antagonists have been shown to prevent the vasoconstriction and the renal failure that follow acute renal ischemia in rats[1].
IC 50
ETA: 9.5 (pA2); ETB: 7.7 (pA2)
TEZOSENTAN Preparation Products And Raw materials
Raw materials
Preparation Products
TEZOSENTAN Suppliers
- Tel
- 18210857532; 18210857532
- Fax
- 86-10-82849933
- jkinfo@jkchemical.com
- Country
- China
- ProdList
- 96815
- Advantage
- 76
- Tel
- 021-50135380
- shchemsky@sina.com
- Country
- China
- ProdList
- 15402
- Advantage
- 60
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 010-56205725
- Fax
- 010-65763397
- waley188@sohu.com
- Country
- China
- ProdList
- 12335
- Advantage
- 58
- Tel
- 025-66028182 18626450290
- yftan@aikonchem.com
- Country
- China
- ProdList
- 16679
- Advantage
- 50
- Tel
- Fax
- -
- eric_feng1954@126.com
- Country
- China
- ProdList
- 9248
- Advantage
- 55
- Tel
- 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 9923
- Advantage
- 65
- Tel
- 15971444841
- Fax
- 18327183813
- amber@biochempartner.com
- Country
- China
- ProdList
- 3061
- Advantage
- 58
- Tel
- +86-400-002-6226 +86-13028896684;
- sales@rrkchem.com
- Country
- China
- ProdList
- 57422
- Advantage
- 58
- Tel
- 15911056312
- liming@bio-fount.com
- Country
- China
- ProdList
- 9729
- Advantage
- 58